| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 20 |
| 1 | PREDNISOLONE ORAL | 20 |
| 2 | PREDNISOLONE ORAL SOLUTION | 20 |
| 3 | MYCOPHENOLATE MOFETIL | 19 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 19 |
| 5 | ALEMTUZUMAB | 18 |
| 6 | BUSULFAN | 18 |
| 7 | CYCLOPHOSPHAMIDE | 18 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENICILLIN V POTASSIUM | 5 | 0.0019 |
| 1 | CANAKINUMAB | 17 | 0.0016 |
| 2 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 3 | BUSULFAN | 18 | 0.0011 |
| 4 | INDOMETHACIN | 14 | 0.0011 |
| 5 | ANAKINRA | 17 | 0.0010 |
| 6 | ALEMTUZUMAB | 18 | 0.0009 |
| 7 | THALIDOMIDE | 17 | 0.0005 |
| 8 | FLUDARABINE PHOSPHATE | 18 | 0.0005 |
| 9 | ADALIMUMAB-FKJP | 17 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 17 | 0.0010 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 2 | Cannabinoid [EPC] | 1 | 0.0001 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 17 | 0.0001 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 15 | 0.0001 |
| 5 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 18 | 0.0001 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 18 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |